Ad
IPHA Stock Quote Trading Chart Innate Pharma S.A.
home / stock / ipha / ipha quote
Quote | Innate Pharma S.A. (NYSE:IPHA)
| Last: | $ |
|---|---|
| Change Percent: | 1.60% |
| Open: | $7.75 |
| Close: | $7.60 |
| High: | $7.75 |
| Low: | $7.57 |
| Volume: | 5,364 |
| Last Trade Date Time: | 02/12/2020 04:44:19 pm |
Quotes are delayed by 15 to 20 minutes.
IPHA Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $ | $7.75 | $7.60 | $7.75 | $7.57 | 5,364 | 02-12-2020 |
| $ | $7.5569 | $7.48 | $7.58 | $7.465 | 4,361 | 02-11-2020 |
| $ | $7.53 | $7.4874 | $7.53 | $7.4874 | 587 | 02-10-2020 |
| $ | $7.34 | $7.64 | $7.64 | $7.32 | 4,490 | 02-07-2020 |
| $ | $7.4085 | $7.37 | $7.455 | $7.27 | 7,541 | 02-06-2020 |
| $ | $7.33 | $7.25 | $7.352 | $7.25 | 543 | 02-05-2020 |
| $ | $7.28 | $7.2084 | $7.3952 | $7.2084 | 1,328 | 02-04-2020 |
| $ | $7.12 | $7.0438 | $7.2078 | $7.0438 | 2,311 | 02-03-2020 |
| $ | $7.08 | $7.02 | $7.08 | $6.71 | 12,435 | 01-31-2020 |
| $ | $6.98 | $6.90 | $6.9979 | $6.88 | 4,216 | 01-30-2020 |
| $ | $7.29 | $7.1321 | $7.29 | $7.1321 | 634 | 01-29-2020 |
| $ | $7.17 | $7.1768 | $7.1929 | $7.14 | 1,666 | 01-28-2020 |
| $ | $7.26 | $7.01 | $7.2969 | $6.8201 | 6,759 | 01-27-2020 |
| $ | $7.42 | $7.28 | $7.42 | $7.28 | 4,043 | 01-24-2020 |
| $ | $7.5328 | $7.68 | $7.73 | $7.36 | 17,572 | 01-23-2020 |
| $ | $7.71 | $7.60 | $7.71 | $7.50 | 14,246 | 01-22-2020 |
| $ | $7.79 | $7.51 | $7.79 | $7.51 | 27,998 | 01-21-2020 |
| $ | $7.62 | $7.605 | $7.6773 | $7.2501 | 15,658 | 01-20-2020 |
| $ | $7.62 | $7.605 | $7.6773 | $7.2501 | 15,658 | 01-17-2020 |
| $ | $7.33 | $7.27 | $7.35 | $7.27 | 16,545 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Innate Pharma S.A. Company Name:
IPHA Stock Symbol:
NYSE Market:
Ad
-
The event will highlight positive results from the TELLOMAK Phase 2 Trial with lacutamab in heavily pretreated patients with relapsed and refractory Sézary syndrome which have been selected for oral presentation at the American Society of Hematology (ASH) Annual Meeting Virtual K...
-
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
-
Innate Pharma S.A. (IPHA) is expected to report for Q3 2023